SABCS 2025
Dec 11, 2025
A New Star at SABCS 2025: BioNTech–BMS’s Pumitamig Redefines Next-Gen Immunotherapy
The 2025 San Antonio Breast Cancer Symposium (SABCS), the world’s leading forum for breast cancer research, highlights cutting-edge progress across the full spectrum of breast cancer, from prevention and molecular biology to new therapies and survivorship. This year’s focus includes several emerging strategies to r...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
